Cellular and T cell engager Immunotherapy
Can Bispecific T Cell Engagers for Multiple Myeloma be Safely Administered in The Community? A Single Center Experience
Rahim Jiwani, MD
Hematology/Oncology Fellow
Allegheny Cance Institute
Pitsburgh, United States